About Jessup

The Phillip C. Jessup Moot Court Competition is the largest and most prestigious moot court competition in the world. Students from more than 80 countries and 550 law schools compete each year in regional competitions for the distinction of proceeding to the International Rounds. Held every spring in Washington, D.C, the International Rounds are conducted together with the Annual Conference of the American Society of International Law (ASIL). The Competition is organized by the International Law Student Association (ILSA).

Simulating a fictional dispute between States brought before the International Court of Justice- the judicial organ of the United Nations, the competition requires each participating team to prepare detailed oral and written pleadings, arguing both the applicant and respondent positions of the case. Thousands of law students from all around the world work yearlong on the Jessup problem, which tackles crucial questions of international law. Only one Israeli team can advance to the international rounds. A national competition is held annually in Tel Aviv for the purpose of determining which school team should proceed. The Hebrew University has participated in Jessup since 2007, and has since claimed the uninterrupted honour of proceeding to the International Championships. Hebrew University students have additionally proved extremely talented in their international performances. In 2008, they achieved sixth place (from approximately 90 teams) in the preliminary rounds, and advanced automatically to the octo-final rounds; whilst in 2009 the Hebrew University team was rated amongst the top twenty-four teams (from approximately 110 teams), and went on to participate in the advanced rounds. Several team members have also been entered on the list of the top 100 oralists, and the team's memorials were graded among the top 15 (11th place in 2008, 13th place in 2009). The 2010-2011 team won all four rounds in the preliminary stages and was ranked 8. The team went to compete in the advanced rounds and for the first time in the school's history has made it to the quarter-finals. Their written memorials were ranked among the top 10 best written submission (10th place). The 2011-2012 team continued this tradition of success, finishing the preliminary rounds in 7th place and its written submissions being ranked 6th. Most recently, the 2012-2013 team equalled the University's record by reaching the quarter-finals of the competition – losing to the competition finalists – in a year in which over 550 institutions around the world participated. For the first time, all the University's oralists eligible for ranking finished in the top 50: David Zlotogorski (36), Ori Pomson (36) and Maya Freund (41). Competition organizers and judges have been repeatedly and deeply impressed by the excellent performance of Hebrew University students.

For more information, see the Jessup site: http://www.ilsa.org/jessup

 
Hebrew University Teams

Hebrew University Jessup teams consist of 4 to 5 specially selected students from the Faculty of Law, who spend the year receiving intensive training in International Law. Particular attention is paid to improving research, writing, and litigation skills of contestants under the tutelage of Adv. Tal Mimran and Ori Pomson (2013-2014).

After committing themselves to a period of substantial research during the fall semester, the Jessup team prepares written memorials addressed to the International Court of Justice based on the competition’s case (the Compromis). The team then presents oral arguments at the Regional Competition in Tel Aviv, which takes place in February of the competition year. The team who wins the Regional Competition proceeds to the International Rounds in Washington D.C.

If you are interested in pursuing an opportunity to partake in Jessup please contact Ori Pomson at: ori.pomson@mail.huji.ac.il

The Current Team 2014-2015

Coaches: Adv. Tal Mimran and Ori Pomson

The Current Team 2013-2014

Coaches: Adv. Tal Mimran and Ori Pomson

• General: The Government of Israel (GoI) has not declared the existence of a state of emergency with respect to the applicability and implementation of international legal instruments to which it is party specifically following the outbreak of the COVID-19 pandemic, nor derogated from its obligations under the ICCPR. However, it relied on various emergency powers under domestic law to regulate a variety of aspects of the legal response to the COVID-19 crisis in a manner that involves limitations on the enjoyment of various human rights.
   
• Emergency powers: On 27 January 2020 the minister of health declared the Novel Coronavirus 2019-nCoV (COVID-19) to be a ‘dangerous contagious disease that creates a severe danger to public health’. [1] Under the Public Health Ordinance of 1940, [2] this declaration empowers the minister of health and officials in the ministry of health to take special measures for addressing a danger emanating from a declared contagious disease that threatens any part of Israel. These measures included ordering self-isolation, restrictions on gatherings, restrictions on movement and forced hospitalisation, wearing of masks in public, and sanctions for failure to comply with the various instructions.
   
• State of Emergency: On 15 March 2020 the GoI began relying on its power to promulgate emergency regulations during a State of Emergency (that have the force of primary legislation). [3] A declaration of a State of Emergency has been in effect in Israel since its establishment in 1948. The state of emergency allows the government to adopt regulations that supersede parliamentary legislation. The legislation that empowers the Knesset to declare a state of emergency does not define what constitutes an ‘emergency’. [4]
   
• State of Emergency legislation: On 23 June 2020 emergency regulations were adopted by parliamentary legislation. [5] On 23 July 2020 they were substituted by comprehensive parliamentary legislation, when the Knesset adopted the Special Powers for Treating the Novel Coronavirus (Temporary Provision) Law, 2020, in effect until 30 June 2021 (hereafter ‘Temporary Provision Law’). [6] According to the Law, the Government may declare an State of Emergency due to Coronavirus (SEdC) if it is convinced that there is a real risk of a broad spread of the COVID-19 and a significant harm to public health, which require action under the law. The Knesset may annul a declaration of SEdC. During a SEdC the government may promulgate regulations to prevent contagion or reduce the spread of the virus, reduce morbidity or protect vulnerable population. Such regulations are in force for up to 28 days and may be extended periodically. They too require parliamentary approval. The regulations may include restrictions on distancing from private homes, subject to various exceptions; social distancing; closure of businesses; closure of educational institutions; and restrictions on public and private transport. They may be adopted only for the time and to the extent required for these purposes, following considerations of alternative, their effect on rights and on the economy. Upon the adoption of the Temporary Provision Law a declaration on a SEdC came into force for 45 days ,[7] which has since been extended periodically, under parliamentary approval. [8]
   
• Special State of Emergency: On 30 September 2020 the Knesset amended the Temporary Provision Law to introduce a ‘Special State of Emergency due to COVID-19’ (SSE), [9] which the government may declare if, during the period of a SEdC it is convinced that there is a broad spread of COVID-19 which causes a severe harm to public health, and there are already full restrictions. Such a declaration may be in force for up to 7 days, and may be extended for up to 21 days altogether; or longer, with parliamentary approval. During a period of an SSE the government may adopt further restrictions over those applicable in a SEdC. 

GA resolutions on the COVID-19 pandemic

• A/RES/74/270: Global solidarity to fight the coronavirus disease 2019 (COVID-19) (3 April 2020): Israel co-sponsored the draft resolution,[10] which was subsequently adopted through the silence procedure.
   
• A/RES/74/274: International cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19 (20 April 2020): Israel co-sponsored the draft resolution,[11] which was subsequently adopted through the silence procedure 
   
• A/RES/74/306: Comprehensive and coordinated response to the coronavirus disease (COVID-19) pandemic (11 September 2020): [12] Israel voted in favour of paragraph 7 of draft resolution A/74/L.92 (relating to reproductive rights) and abstained on its paragraph 34 (on considering COVID-19 experience in enhancement of global transport).[13] Israel voted against the amendment in draft resolution A/74/L.93 [14] It then voted against the adoption of the draft resolution as a whole. It explained its vote as follows:[15]

We believe that the text put forward by the co-facilitators was a comprehensive and balanced one.  We were disappointed by the amendment put forward on paragraph 20 of the draft omnibus resolution, which threatened the delicate balance in the text achieved by the co-facilitators, and we therefore voted against the resolution. …. Israel remains committed to working together with the international community in the fight against the coronavirus disease.

• A/RES/74/307: United response against global health threats: combating COVID-19 (11 September 2020): Israel co-sponsored draft resolution A/74/L.57 and voted in favour of it, resulting in Resolution 74/307.[16]
   
• A/RES/75/4: Special session of the General Assembly in response to the coronavirus disease (COVID-19) pandemic (5 November 2020): Israel abstained in the vote on a proposed amendment relating to speakers at the opening of the special session.[17] Israel proposed an amendment to the operative provisions on participation in the special session so that instead of referring to ‘Member and Observer States, the European Union’, and ‘each Member State, Observer State, and the European Union’, they would refer to ‘Member State and observers of the General Assembly’.[18] It further voted against a proposed oral amendment by the US to delete reference to the role of the WHO in the response to COVID-19.[19] Following the rejection of its proposed amendment, Israel abstained in the vote on the draft resolution as a whole,[20] stating that it[21]

regrets having had to abstain on the modalities resolution today (resolution 75/4). We would have preferred to vote in favour but could not do so due to the political pressure that prevented the resolution from using the agreed participation formula. We therefore dissociate from operative paragraphs 3(c) and 4(a).

• A/RES/75/17: International cooperation to address challenges faced by seafarers as a result of the COVID-19 pandemic to support global supply chains (1 December 2020): Israel joined in the adoption of the resolution without a vote.[22]
   
• A/RES/75/156: Strengthening national and international rapid response to the impact of the coronavirus disease (COVID-19) on women and girls (16 December 2020).[23]
   
• A/RES/75/157: Women and girls and the response to the coronavirus disease (COVID-19) (16 December 2020).[24]  Israel co-sponsored the resolution at the 3^rd committee.[25]

• Notification under the International Health Regulations: On 27 January 2020 the Minister of Health added the ‘Novel Coronavirus 2019-nCoV infection’ to the list of diseases of international importance that require immediate notification under the WHO’s International Health Regulations (2005).[1]

WHO standards and guidelines:  

• At the WHO Executive Board session Israel stated: ‘The WHO’s publishing of hundreds of COVID-19 related guidance materials have been invaluable to Israel and our partners in managing our pandemic response, and the transparent, evidenced-based information has been especially important’.[2]
   
• CAPSCA: Israel is a member of CAPSCA (a voluntary cross-sectorial, multi-organizational collaboration programme managed by ICAO in partnership with the WHO, to combine efforts to improve preparedness planning and response to public health events that affect the aviation sector).

Entry and exit through airports

• On 13 August 2020 the GoI adopted regulations regarding requirements on operating airports and flights for the prevention of COVID-19 contagion.[1]
   
• On 25 January 2021 the GoI amended the regulations to prohibit the entry of foreign passenger aircrafts other than in exceptional situations.[2]
   
• On 6 February the GoI amended the regulations prohibiting entry or exit of public (scheduled) flights (of persons holding exit or entry permits) other than by Israeli flight operators.[3] This provision was rescinded two weeks later.[4]
   
• As of 16 March 2021, flight slots for public flights are to be allocated to the extent possible inter alia equally among flight operators servicing the various destinations decided on.[5]

Compensation for flight cancellations (relating to Montreal Convention 1999, art 22(1))

• On 13 July 2020 the Knesset adopted legislation[6] that reduces the liability of airlines for flight cancellation or for deviation of more than 8 hours from schedule (ahead or behind). This liability includes for assistance services, refund or an alternative flight, and compensation for the inconvenience. The law reduces the liability so as to ensure the financial viability of airlines.[7]

Health standards in aviation:

• Reliance on European standards: On 13 August 2020 the GoI adopted regulations on restrictions on entry into airport terminals and movement within them, check-in, restrictions on boarding, maintenance of cleanliness and sterilization, physical conditions on board, inflight service and data collection. The regulations require operators of international airports and operators of airline carriers to adopt work procedures and methods in compliance with the regulations that would comply, inter alia, be ‘as far as possible, with due regard to’ the EASA Guidance on Management of Crew Members in Relation to the SARS–CoV–2 Pandemic, the COVID–19 Aviation Health Safety Protocol, and the EASA Interim guidance on Aircraft Cleaning and Disinfection in relation to the SARS–CoV–2 Pandemic. The regulations also adopt the EASA Interim Guidance on Aircraft Cleaning and Disinfection in Relation to the SARS–CoV–2 Pandemic as the standard for cleaning and sterilising airline carriers.[8]

Alleviations to national regulations relating to international aircraft standards and recommended practices:

• In accordance with Article 38 of the Chicago Convention and temporary exemptions and exceptions as described in the Safety Oversight Manual (Doc 9734), Israel informed ICAO of the following COVID-19 related alleviations with regard to core and extended standards, necessary to maintain aviation operations during the COVID-19 pandemic:[9]
   
• Standard 1.2.4.4.1: In accordance with emergency regulations (new Corona Virus) (extension of validity period and postponement of dates), 2020, the validity period of airmen medical certificates issued by the CAAI whose validity period end on the dates between 10 March 2020 and 10 May  2020 is automatically extended by two months from the final date expiry of the individual medical certificate. Israel shall recognize differences filed by other states as long as long as they are within the guidelines presented in the Israeli details of difference and mitigations.
   
• Standard 9.4.1.1: Exemption FSD-153-2020 granted to Israel-certified airline El Al allows crew members to be assigned to operate at the flight controls despite not having met the recent experience requirements of the standard, provided the following conditions are met: 1) the flight crew member operating the controls has conducted, either 3 take-offs and 3 landings within the preceding 120 days, or one take off and one landing within the preceding 30 days, in an aircraft of the same type or in a flight simulator approved for the purpose. A flight crew member who has been active in the preceding 120 days, but who does not meet the above conditions, may regain their qualification by conducting a take off and landing under the supervision of a company check airman. 2) The flight crew member is not considered "inexperienced" under the company's procedures. 3) The other flight crew member assigned to the take-off and landing meets the requirements of the standard. 4) The Pilot-in-command has accumulated 5,000 hours of flight experience in large airplanes, at least 100 of which on an aircraft of the same type being operated.
   
• Rationale and conditions/mitigations: Minimization of regular flight schedule and lack of domestic access to approved simulators requires alleviation to the recent experience requirements, provided the following conditions are met: 1) The exemption is granted until 30/11/2020, unless otherwise suspended. 2) A risk assessment and mitigation activities are conducted for the operations under the Air operator's SMS. Israel shall recognize differences filed by other states as long as they are within the guidelines presented in the Israeli details of difference and mitigations. 
   
• Standard: 9.4.4.1: Exemptions granted to Israeli Air carriers (certified under chapter 13 of IANR.OPS) allow extension of the validity of a proficiency check for a period of four months after its individual expiry for each individual flight crew, provided the following is met: 1) The flight crew member has received refresher training, followed by the completion of an assessment by means established by the operator to determine that the required level of knowledge to operate the applicable class or type is maintained. That assessment shall include class – or type – specific abnormal and emergency procedures, and shall be approved by the CAAI rationale and conditions/mitigations: Lack of domestic access to approved simulators requires temporary extension of proficiency check validity provided the mitigation measures provided in the exemption are taken, and subject to the operation meeting the following conditions: 1) The exemption is granted until 30/11/2020, unless otherwise suspended. 2) A risk assessment and mitigation activities are conducted for the operations under the Air operator's SMS. Israel shall recognize differences filed by other states as long as they are within the guidelines presented in the Israeli details of difference and mitigations. 

Measures affecting trade in intellectual property rights (relating to TRIPS)

• Use without authorisation of right holder: On 18 March 2020, Israel's minister of health issued a permit to the Emergency Department at the Ministry of Health and to K.S. Kim International Ltd., to exploit a patent-protected invention by importing generic versions of lapinovir/ritonavir manufactured by Hetero in India, for the purpose of treating COVID-19 patients. The Permit states that ‘[t]he said exploitation is necessary for the maintenance of essential supply or services.[1]
   
• Israel's Patent Authority fast-tracked LPV/r's approval, along with seven other medicines for the treatment of COVID-19.[2]

Measures affecting trade in goods (relating to GATT Articles XI:2(a) XX(b))

• Temporary export licensing requirements on medical equipment: on 6 May 2020 Israel informed the WTO of temporary export licensing on requirements on medical equipment (eg alcohol, face masks, medical oxygen, swabs, personal cleaning products containing ethyl/isopropyl alcohol, disinfection products, artificial respiration devices) (HS 2207; 2208; 2804.40; 3005; 3402.20; 3808.90; 6210; 6307.90; 8413; 8414; 8481.80; 9018; 9019.20; 9020), due to the COVID-19 pandemic, effective until 30 May 2020.[3]
   
• Temporary export licensing requirements on medical equipment: on 16 June 2020 Israel informed the WTO oftemporary export licensing requirements on medical equipment (eg alcohol, swabs, personal cleaning products containing ethyl/isopropyl alcohol, disinfection products, face masks, artificial respiration devices, and respirators) (HS 2207; 2208; 3005; 3402.20; 3808.90; 6307.90; 9019.20; 9020), due to the COVID-19 pandemic, effective until 15 October 2020.[4]
   
• New temporary export licensing scheme: on 30 October 2020 Israel informed the WTO of a new temporary export licensing scheme, eliminating export licensing requirements for respiratory machines, and new export licensing requirement for a number of COVID-19 tests products (HS 2207; 2208; 3002.15.90; 3005; 3402.20; 3808.90; 3822.00.90; 3923.30.90; 3923.90.00; 4015.19.00; 6307.90), effective until 30 November 2020.[5]

Measures taken in the Agricultural sector

• Israel adopted emergency regulations in order to reduce the infection and the virus spread. According to the notification ‘[a]gricultural production and related industry and services are considered essential and are therefore excluded from these regulations. Services in farms and ports of entry, such as plant protection inspectors and veterinarians, have continued’. In addition, following daily assessment of the availability of fresh agricultural produce, voluntary duty-free TRQs have been temporarily increased to import onions, cucumbers and eggs. The plant protection and inspection services (PPIS) and veterinary and animal health services (IVSAH) have also facilitated imports by accepting official and scanned copies of original phytosanitary or health certificates, as well as e-certifications that can be verified, for specific products and under certain conditions.[6]

Support measures

Israel informed the WTO of COVID-19 temporary support measures as follows:[7]

• MSME-specific support measure: On 6 April the central bank announced that it will provide the banking system with fixed-rate loans at 0.1% interest rate, for a term of 3 years, with the goal of increasing the supply of bank credit to small businesses. The plan will be in operation until the end of May, and its scope will be NIS 5 billion.
   
• MSME-specific support measure: Loan guarantees for SMEs: On 4 May the GoI has expanded the loan fund for SMEs from NIS 8 billion to NIS 14 billion. The GoI guarantees 85% of each loan but guarantees are limited to 15% of overall losses on all loans. Loans have a maturity of up to 5 years, with lower collateral requirements (5%). The first year is interest rate free. The time required for banks to provide credit approval is reduced to 7 working days. Amount: NIS 14 billion.
   
• Businesses are able to apply for accelerated depreciation (Double-Declining Depreciation) on equipment purchased for the business from September 1, 2020 to June 30, 2021 (effective 9 November 2020).
   
• Arrangements for the distribution of VAT payments of businesses whose turnover in March-December 2020 decreased by more than 25% compared to their turnover in March-December 2019 (effective 2 March 2021).
   
• MSME-specific support measure: Tax and payment deferrals (NIS 9 billion). Payment of VAT, municipal taxes, social security contributions, utility payments, government fees have been deferred for SMEs until the end of April (effective 14 April 2020).
   
• MSME-specific support measure: Grant for small and medium businesses (up to NIS 400 million turnover) (NIS 12.7 billion as of 3 March 2021), once every two months, from May 2020 to June 2021, of up to NIS 500 000 to cover fixed expenses, Amount: NIS 12.7 billion.
   
• MSME-specific support measure: Grant to self-employed (NIS 15.0 billion as of 3 March 2021): A grant of 70% of twice the average monthly taxable income up to NIS 15 000, once every two months, from May 2020 to June 2021, for self-employed that experience a 40% decrease in activity. Amount: NIS 15.0 billion.
   
• [MSME-specific support measure] State Guarantee Fund for Small Businesses - NIS 8 billion for public loan guarantees to SMEs.

Participation in WTO statements

• 5 May 2020: Israel participated in a Statement on Covid-19 and the Multilateral Trading System.[8]
   
• 14 May 2020: Israel participated in a Statement on Highlight in the Importance of MSMEs in the Time of COVID-19.[9]

State immunity  

In Class Action 2069-04-20 Freedom Watch v People’s Republic of China, the Attorney General submitted an intervening brief (8 November 2020), according to which:[10]

29. On the factual level, the action details a series of acts that the petitioners attribute to the PRC and persons acting on its behalf that have allegedly taken place in the territory of the PRC. According to the legal submission, the petitioners detail that the COVID-19 virus was spread in Israel, but other than a general statement, there is neither claim nor example of a specific event of spreading in Israel by the respondent, and all the claims detailed in the action refer only to acts allegedly carried out in the territory of the PRC. Accordingly, and since the tort exception as defined in the Foreign State Immunity Law does not apply, the respondents are immune to the action…

30. … The tort exception to foreign state immunity from civil action, under Israeli law, and international law and in comparative law, contains a clear requirement that the acts attributed to the foreign government be carried out in the territory of the forum state. 

31. Since the action in question does not point to acts carried out by the PRC or anyone on its behalf in the territory of Israel, the PRC, the government authorities in China and officials representing China acting in their capacity enjoy immunity from the action in Israeli courts.

Foreigners

Entry and sojourn

• Prohibition on entry of foreigners: Since 12 March 2020 non-resident foreign nationals have denied entry to Israel, pursuant to the Minister of Interior decision. Permission to enter was to be considered for foreign nationals who could prove that they have a place and are able to go into a 14-day isolation.[1] On 18 March 2020, the ban was expanded so that foreign nationals were barred even if they have proven the ability to stay in quarantine.[2]

• Extension of visas: Starting 16 March 2020, the Population and Immigration Authority announced that visas of various types expiring from 12 March 2020 would be automatically extended until 30 June 2020.[3] Additional extensions was later granted until 31 August 2020,[4] and 30 March 2021.[5] Other than in exceptional circumstances,[6] tourist visas (B2) have not been automatically extended.[7] Tourist visas falling within specific categories were extended automatically until 30 June 2020.  
   
• Restrictions on entry: On 5 February 2021 the GoI adopted regulations on entry into and exit from Israel.[8] The regulations prohibit entry by non-resident foreign nationals other than by exceptional permit granted on an enumerated list of 4 grounds.[9] The list exceptions has been modified, for example to allow entry of foreign workers necessary for the purpose of maintaining the functional continuity of the economy.

Exit

• Restrictions on exit for persons required to self isolate: Under regulations of 14 August 2020, persons required to self isolate are not permitted to exit Israel.[10] To ensure this, information was to be transferred from the health systems to the border control systems regarding persons required to self isolate.[11] Foreign nationals leaving Israel before the end of their mandated isolation period without special permission would be in violation of the laws of the State of Israel and would not be approved entry to Israel on their return. A list of states from which entry is entirely prohibited has been modified from time to time.[12]

Diplomats

• Exclusion from exit restrictions: On 1 October 2020 the regulations limiting exit of non-resident foreign nationals were amended to exclude holders of foreign diplomatic or service passports, diplomatic or service visas, UN travel documents or persons registered in the Ministry of Foreign Affairs as diplomatic or consular staff or officers of international organisations.[13]
   
• Family members of international employees (international organisations) who hold a Type 2 residence permit (B2) are required to apply for an extension.[14]
   
• Exclusion from travel destination restrictions: On 30 April 2021 the GoI adopted regulations prohibiting exit from Israel to a list of enumerated states, other than by exceptional permit. Israeli Diplomats and holders of foreign diplomatic or service passports, diplomatic or service visas, or persons registered in the Ministry of Foreign Affairs as diplomatic or consular staff were excluded from these regulations.[15]
   
• Exclusion from border crossing restrictions: From time to time the minister of interior declared the temporary closure of land border crossings. On 5 February 2021 the GoI adopted Regulation restricting exit from Israel through specific land border crossings.[16] Diplomats have since been exempted from these restrictions.[17]

Nationals and permanent residents

• Legislative framework: On 4 February 2021 the Temporary Provision Law was amended,[18] empowering the government to limit, during a SEdC, entry into Israel and exit from it, except for the exit of non-national non-residents. According to the amendment, such limitations may be permitted only if the government is convinced, based on an epidemiological opinion by the ministry of health, relating to morbidity  rates outside Israel, that there is an increased risk of arrival of infected persons to Israel, and that their entry may cause a significant exacerbation of the  morbidity level in Israel; that there are no alternative means; and only if the government has considered the need for such limitations against the right to entry into Israel and exit from it. The Law establishes an exceptions committee to consider individual cases. 

Exit

• Restrictions on exit: On 5 February 2021 the GoI adopted regulations imposing a general prohibition on exit from Israel extending to Israeli nationals and Israeli residents (unless residing abroad), other than by individual permit from an exceptions committee.[19] According to the regulations exit permits could be available on an enumerated list of 7 enumerated grounds.[20] The regulations expired on 20 March 2021.[21]

Entry

• Restrictions on entry: According to the same regulations, no person could enter Israel other than by permit granted by the exceptions committee. Such permits could be available to Israeli nationals or permanent residents, as well as to spouses or parents of Israeli nationals or permanent residents, on an enumerated list of 8 grounds.[22] Over the course of the following month the exceptions were modified.

• On 18 February 2021 the regulations were amended (effective 21 February) to allow pubic flights to or from New York and Frankfurt, as well as non-public flights receiving permission and required for the takin management of Israel’s foreign relations or national security; for carrying professional sportspersons to an international competitive event; for bringing olim (immigrants eligible for citizenship under Israel’s Law of Return; or required for humanitarian or special reasons. The maximum number of passengers was set at 2000 arrivals and 2000 departures daily.[23]
   
• On 7 March 2021 the requirement of entry permit was lifted until 20 March for holders of Israeli passports or laissez passer for permanent residents may enter without prior permit.[24] In addition, persons recovering from COVID-19 or vaccinated were exempted from the requirement of a permit from the exceptions committee.[25] The list of ports of departure and destination was extended to eight locations worldwide, but the number of daily entries and departures remained under quota to be determined according to the air travel outline and to the scope of flights that will be determined by the Ministry of Transportation in coordination with the Ministry of Health. This quota will also include passengers entering through the land border crossings.[26] Non-public flights upon permission were expanded to include travel to Israel of essential foreign workers.[27]
   
• On 18 March 2021 the Supreme Court sitting as High Court of Justice held that the limitations on entry of Israeli nationals and permanent residents were unconstitutional and could not be extended beyond their expiration date of 20 March.[28]

• The only specific additional restriction provided in the 30 September 2020 amendment to the Temporary Provision Law, introducing a ‘Special State of Emergency due to Coronavirus’ (SSE),[1] was the exclusion of participation in a demonstration from the exceptional circumstances allowing individuals to distance themselves from home, so that participation in a demonstration would be permitted only within the same distance from home as any other activity.
   
• The amendment contained a declaration of an SSE which remained in force until 13 September.[2] Since distancing from home was limited at the time to 1000 meters, the declaration effectively prohibited demonstrations at a distance of more than 1000 meters from one’s home. On 4 April 2021 the Supreme Court sitting as High Court of Justice ruled that the restrictions on distancing from the home for the purpose of demonstration was disproportionate and therefore unconstitutional.[3]

Israel

• Israel is taking part in the COVAX alliance.[1]

Treatment of populations lacking immigration status 

• The Head of the Medical Directorate in the Ministry of Health has instructed the general hospitals to provide any necessary response to persons lacking immigration status in Israel and persons from marginalised populations. She also noted that Magen David Adom should offer a response to this population as to any resident.[2]
   
• In a later correspondence the Head of the Medical Directorate in the Ministry of Health instructed the general hospitals and Magen David Adom that patients suspected of being infected or confirmed as infected must be admitted for treatment, even if the patient cannot pay and has no insurance. This instruction refers inter alia to infiltrators/asylum seekers and foreign/migrant workers.[3]
   
• On 24 December 2020 the Population and Immigration Authority stated based on information from the ministry of Health that foreign workers in the home-based caregiving sector who are insured by their employers are entitled to be vaccinated with their employers regardless of their national health insurance status. Furthermore, the ministry of health is intending to vaccinate all foreign workers in Israel regardless of their medical insurance.[4]
   
• On 30 December 2020 the Ministry of Health declared that persons present in Israel who are over 60 years old have been prioritised for vaccination similarly to Israeli nationals their age.[5]
   
• On 21 January 2021 the Director of the Section for Policy Planning in the Ministry of Health Dr. Shlomit Avni announced that the Committee on Vaccines and the Director-General of the ministry of health have confirmed a decision to vaccinate all status-less persons whose center of life is in Israel and qualify under the age prioritization schedule.[6]
   
• Asylum seekers: On 9 February the Municipality of Tel Aviv opened a vaccination center for asylum seekers and migrant workers age 16 and upwards at no cost. Over 20,000 persons have been vaccinated.[7]
   
• On 10 February 2021 the Ministry of Health decided that vaccines would be provided to persons lacking immigration status providing proof of being present in Israel half a year or longer, as well as to any person lacking immigration status over the age of 50.[8]

West Bank and Gaza

Health services in West Bank and Gaza - general

Legal obligations:

• On various occasions the GoI stated that.[9]

under the Interim Agreement, the responsibility and authorities in the health sphere with regard to the whole of the Palestinian population in Judea and Samaria and the Gaza Strip have been transferred to the Palestinian Authority. Accordingly, the responsibility for containing and addressing the spread of COVID-19 in these territories lies with the Palestinian Authority. Furthermore, in 2007 the Hamas took over the Gaza Strip through a military coup, and the medical response to residents of the Strip is provided also through the Gazan health authorities, that are subject to the Hamas terrorist organization. In this state of affairs, Israel acts in cooperation and coordination with the relevant Palestinian Authority organs and various actors in the international scene, to provide a plenteous and varied assistance for the Palestinian population’s combatting COVID-19. All this, far beyond Israel’s obligations under law.

The High Court of Justice noted that prima facie, the State of Israel acts in a variety of fashions, including far beyond the required in the circumstances.[10]

• Similarly, in February 2021 the GoI stated that ,under the Israeli-Palestinian Interim Agreement regarding the West Bank and Gaza Strip signed in September 1995, the responsibility and authorities in the health sphere with regard to the Palestinian population the Gaza Strip are in the hands of the Palestinian Authority, who bears the responsibility to respond to health needs of this population; the medical response to Gaza residents is given in practice by the Gaza health authorities, who are since 2007 subject to the Hamas regime’.[11]
   
• The GoI repeated its consistent view that international human rights treaties to which Israel is party do not apply outside its sovereign territory.[12]

Policy

• At the end of January 2021 Israel stated that it has ‘a vested interest in ensuring the vaccination of the population of the Palestinian Authority, while assuring the Palestinian Authority maintains its own fully functioning health system’.[13]
   
• Israel ‘remains committed to actively promoting and improving health standards globally and regionally by strengthening the close collaboration with all partners, including the Palestinians, to ensure adequate preparedness and response to the current pandemic’.[14]
   
• ‘Given the daily contact between the two populations, the epidemiological position of the ministry of health is that the territory of the State of Israel and the Palestinian Authority is one unit from an epidemiological perspective, given the size and geopolitical composition of the territory. Accordingly, from a narrow epidemiological perspective the areas of the Palestinian Authority in Judea and Samaria should be regarded as one territory with the State of Israel. Therefore, the position of the ministry of health is that Israel sees value and health benefit in the Palestinian Authority coping successfully with the pandemic and accordingly also in the Palestinian population in Judea and Samaria being for the most part vaccinated. Since the crossing over between Israel and the Gaza Strip are limited, the risk of infection from the Gaza Strip territory into Israel is lower, but still exists.[15]

West Bank

General:

• Efforts undertaken by the GoI to assist in curbing the spread of COVID-19 with regard to the Palestinian Authority/West Bank include calling on the international community to support the United Nations 90-day programme and direct international aid so that the Palestinian Authority can be better equipped to manage the COVID-19 crisis; Joint consultations and deliberations between expert-level officials from Israel, UN and PA; Training and guidance of Palestinian medical teams, and delivery of medical supplies to the Palestinian Authority.[16]
   
• Israel maintains continuous contact with Palestinian authorities to consider assistance with combatting COVID-19, and requests as for vaccines and other forms of assistance are considered in light of relevant considerations.[17]

Provision of medical supplies from Israel and third parties to the West Bank:

• Israel has transferred to the Palestinian health ministry 1950 testing kits and 2400 nasal swabs. In addition, international donations including from the WHO have been transferred to the Palestinian Authority including emergency room beds, respirators and auxiliary equipment, testing kits and swabs, medication and perishable medical supplies.[18]

Vaccination of Palestinians employed in Israel and in Israeli settlements: 

• On 10 February 2021 the Ministry of Health decided that vaccines would be not be provided to Palestinians employed in Israel, whether holding a work permit or otherwise.[19]
   
• On 8 March 2021 the ministry of health and the military authorities began a vaccination campaign at various crossings and Israeli industrial areas across the West Bank, for Palestinian employees who hold a valid work permit in Israel or in the Israeli settlements in the West Bank.[20] Over the course of the following two weeks, every employee who wishes to do so will be able to be vaccinated at one of the vaccination stations in the crossings, in coordination with their employer and the relevant government authorities.[21] By 29 April 2021, over 104,000 Palestinians holding employment licenses had received the second doze of the vaccines and some 3000 others received a first doze.[22]
   
• Some 4000 Palestinian have been vaccinated under Israeli frameworks (medical teams, teachers and persons insured under national health insurance).[23]

Provision of vaccines from Israel to the West Bank:

• Following a request of the Palestinian Authority, in January 2021 Israel provided, as a humanitarian gesture, vaccines for 100 medical personnel over 60 years old who are treating COVID-19 patients in the West Bank (2 batches of 100 doses). Subsequently, the Israeli authorities transferred 5000 vaccine doses to medical teams in the Palestinian Authority.[24]
   
• On 23 February 2021 the Office of the Prime Minister stated that ‘[d]ue to the accumulation of a limited quantity to unused vaccines, it has been decided to assist Palestinian Authority medical teams and several of the countries that contacted Israel with a symbolic quantity of vaccines’.[25]
   
• On 18 June 2021 the GoI announced that Israel and the Palestinian Authority have reached agreement on a barter of vaccine dozes, according to which Israel will transfer to the Palestinian Authority about a million dozes that are about to expire, in exchange for Pfizer’s next shipment to the Palestinian Authority, due in September-October 2021.[26]

Transfer of vaccines from third parties to the West Bank:

• Under the Interim Agreement, importation of pharmaceuticals to the West Bank are subject to the regulatory framework applicable in Israel. Requests for importation of pharmaceuticals (through COGAT and the taxation authority to the ministry of health) are generally approved from the medical regulatory aspect very quickly. Vaccine donations are exempted from the regular approval procedure and are approved immediately.[27] The medical regulatory framework does not hinder the Palestinian Authority from purchasing vaccines that have not been approved for importation for use within Israel.[28]
   
• According to COGAT, over the months of February and March 2021, 223,140 vaccination dozes were transferred to the Palestinian Authority through WHO under COVAX, from China, from the Serum Institute India and from Russia.[29] In late May and early June 2021, 218,560 additional dozes were transferred from COVAX, UNICEF, WHO and Qatar. Additional requests for transfer of vaccines are under review and in the absence of security obstacles the tendency is to approve them.[30]
   
• According to COGAT, in late May and early June 2021 Israel provided 145,300 dozes purchased by the Palestinian Authority.[31]

Movement of COVID-19 patients from Israel to the West Bank 

• Israel coordinated with the Palestinian Authority the transfer of Palestinians suspected or confirmed as carrying COVID-19 patients from Israel to the West Bank, and provided the Palestinian Authority with names of Palestinians entering Israel so that they can be isolated and monitored once they have entered the West Bank.[32]

Gaza

General:

• Efforts undertaken by the GoI to assist in curbing the spread of COVID-19 include delivery of testing and protection kits to the Gaza Strip, and willingness to assist in laboratory testing; and maintaining commercial crossings into Gaza open for the transfer of goods and assistance.[33]

Transfer of medical supplies to Gaza:

Legal obligations: 

• ‘Israel recognises that the international law of armed conflict applies to the conflict between Israel and Hamas in Gaza. According to these laws, Israel is obligated to allow neutral third parties to transfer equipment and vital medical response to the civilian population in Gaza, including life-saving vaccines, subject to security considerations’.[34]

Practice: 

• ‘Israel facilitates transfer of provisions and assistance to Gaza, subject to security considerations and technical arrangements’.[35] Israel allows entry of medical teams subject to a security check.[36]
   
• With regard to dual-use items that under the law require export permit in order to be transferred to Gaza, some relaxations have been approved in light of changing circumstances and concrete needs.[37] Vaccines against Covid-19 are not regarded as dual-use items.[38]
   
• Numerous and varied additional measures, have been taken relating to addressing COVID-19 in Gaza that cannot be divulged due to a danger of harming Israel’s foreign relations’.[39]

Provision of vaccines from Israel to Gaza:

• As of 10 May 2021, Israel did not intend to provide vaccines to Gaza.[40]

Transfer of vaccines from the Palestinian Authority and third parties to Gaza:

• ‘The prime minister has confirmed that the Palestinian Authority should not be prevented from transferring vaccines to Gaza, provided that those are not funded by Israel or emanating from Israeli stocks’.[41]
   
• ‘Should a request be made by neutral third parties, or by the Palestinian Authority who has the authorities under the Interim Agreement in this context, Israel is obligated under the laws of war in light of the armed conflict between Israel and Hamas and other terrorist groups in Gaza, to allow entry of the said vaccines into Gaza, subject to security considerations’.[42]
   
• On 4 February 2021 the Palestinian Authority received a shipment of Sputnik vaccines (anticipated at 5,000 according to earlier reports) by donation from the Government of Russia. On the same day the Palestinian Authority requested to transfer 1,000 doses to Gaza. The request was approved by the Israeli authorities and the vaccines were transferred.[43] Over the course of February and March 2021, 60,000 vaccine dozes were provided to Gaza through the border with Egypt, and 11,700 vaccine dozes were provided by the WHO under COVAX through Israel.[44] Over the months of April, May and June, 74,200 dozes were received in Gaza from UNICEF, COVAX and WHO, as well as 30,000 from the United Arab Emirates, provided through Rafah Crossing (with Egypt). Requests for additional transfers of vaccine dozes and diluters have been received, some have already been approved by the ministry of health.[45]

Entry of COVID-19 patients from Gaza to Israel or passage through Israel to the West Bank: 

• In accordance with the general policy regarding entry for medical treatment of Gaza residents into Israel, or through Israel to the West Bank, entry is allowed for life-saving treatment or that without which the quality of life is dramatically harmed, if such treatment is unavailable in Gaza. Requests for such entry are channelled through the Civil Palestinian Committee to the Gaza Liaison office and are considered in light of the policy, of specific security considerations, and political considerations.[46]
   
• In February 2021 the GoI noted that requests of COVID-19 patients from Gaza to enter medical treatment in Israel or the West Bank are refused since they do not qualify under the policy approved by the Supreme Court. Furthermore it stated that ccording to the information available to it, medical treatment for COVID-19 is fully available in Gaza and requests are therefore refused.[47]